What Has Been the Progress and Growth of the COVID-19 Saliva Screening Test Potential Market in Recent Years?
The covid-19 saliva screening test potential market has seen considerable growth due to a variety of factors.
• The COVID-19 saliva screening test potential market has expanded strongly in recent years. It will grow from $3.9 billion in 2024 to $4.29 billion in 2025, at a compound annual growth rate (CAGR) of 9.9%.
This growth is due to the potential for home testing, the unprecedented need for diagnostic testing, rising public awareness, and increased investment in research and development.
What Is The Expected Growth In The COVID-19 Saliva Screening Test Potential Market Size Evolve over the Forecast Period?
The covid-19 saliva screening test potential market is expected to maintain its strong growth trajectory in upcoming years.
• The COVID-19 saliva screening test market is expected to grow to $6.17 billion by 2029, at a CAGR of 9.5%.
Growth is attributed to the integration of screening programs, regulatory support, demand for rapid point-of-care tests, population growth, and e-commerce. Trends include increased adoption in non-healthcare settings, digital health platform integration, next-gen technologies, technological advancements, and strategic partnerships.
What Main Forces Are Fueling Expansion In The COVID-19 Saliva Screening Test Potential Market?
The growing healthcare expenditure is expected to spur the growth of the COVID-19 saliva screening test market. Healthcare expenditure refers to the total spending on healthcare services and products, including prescription medications, hospital stays, doctor visits, medical devices, and public health campaigns. Factors like minimally invasive surgeries, advanced diagnostic technologies, and increased investment in R&D for new drugs contribute to the rise in healthcare spending. This financial growth supports the broader use of COVID-19 saliva screening tests, enhancing pandemic control efforts and improving health outcomes. For instance, in 2022, the UK’s healthcare expenditure reached $354.88 billion (£283 billion), marking a 0.7% increase from 2021, according to the Office for National Statistics. This surge in healthcare spending supports the growth of the COVID-19 saliva screening test market.
What Are The Primary Segments In The Global COVID-19 Saliva Screening Test Potential Market?
The COVID-19 saliva screening test potential market covered in this report is segmented –
1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing, Decentralized Testing
Subsegments:
1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports
2) By Sports Arenas: Stadiums, Arenas, Event Halls
3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs
4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks
5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas
6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites
7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers, Other Public Or Private Venues
Pre-Book The COVID-19 Saliva Screening Test Potential Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The COVID-19 Saliva Screening Test Potential Market?
Companies in the COVID-19 saliva screening test market are developing data-sharing platforms to enhance communication and collaboration in testing and tracking. In May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. This initiative focuses on improving public health emergency responses, ensuring efficient strategies during pandemics and other crises.
Who Are the Key Players In The COVID-19 Saliva Screening Test Potential Market?
Major companies operating in the COVID-19 saliva screening test potential market are:
• Roche Diagnostics Corporation
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Becton Dickinson and Company
• Danaher Corporation
• University of North Carolina at Chapel Hill
• Hologic Inc.
• Beaumont Health
• PerkinElmer Inc.
• Quidel Corporation
• University of Illinois at Urbana-Champaign
• Cepheid
• Seegene Inc.
• ARUP Laboratories
• Vatic Health Limited
• Ambry Genetics Corporation
• LumiraDx Ltd.
• Yale School of Public Health
• Gravity Diagnostics
• Psomagen Inc.
• Fluidigm Corporation
• Phosphorus Diagnostics LLC
• DxTerity Diagnostics Inc.
• University of Notre Dame
• MOgene
• FLuroTech Ltd.
What Is The Most Dominant Region In The COVID-19 Saliva Screening Test Potential Market?
North America was the largest region in the COVID-19 saliva screening test potential market in 2023. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
